Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies?
SPRUCE
1 other identifier
observational
120
1 country
1
Brief Summary
The aim of this study is to try and find links between the microscopic organisms (such as bacteria, yeasts and viruses) in the vagina, and twin pregnancies that deliver too early (preterm birth). Being born earlier than expected (preterm birth) happens in over half of twin pregnancies with 1 in 10 sets of twins delivering before 32 weeks gestation. Sometimes, when birth happens very early, babies can be at risk of serious harm including damage to the brain, lungs and bowel - all of which can result in life changing disabilities. How severe these problems are is related to how early they are born. Unfortunately, tests used to find women at risk of preterm birth have only been proven to work when the woman is carrying one baby, not twins, and at present no treatment has been shown to be effective in stopping a twin pregnancy from delivering early. Preventing twins from being born too early is therefore a target for research by the NHS and patient groups including the James Lind Alliance. It is normal for every woman to have microscopic organisms (such as bacteria, yeasts and viruses) in the vagina. New interest has been shown at looking closely at these organisms during pregnancy. These organisms can change and may be related to the number of weeks a woman will go into labour, however to date all research on this has been conducted in pregnancies with only one baby. We want to explore these organisms in twin pregnancies; taking swabs from the vagina at 16- and 28-weeks of your pregnancy, along with at the time of birth. Information will be gathered on the organisms present in the vagina (both of women that deliver too early and those that deliver on time), hoping this information will help us understand why preterm birth happens and help predict the chances of preterm labour in twin pregnancies. By identifying specific organisms linked with preterm birth, we also hope to be able to guide new targets for treatments to prevent preterm birth in twins in future. Due to the small number of twin pregnancies, measurements of how 'stiff' the neck of the womb (cervix) are along with blood samples will be taken. Research has shown that there may be links with how stiff the neck of the womb is and premature birth as well as markers within the blood that may help us predict preterm birth that are yet to be discovered. This will provide the foundations for a future research study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2022
CompletedFirst Submitted
Initial submission to the registry
August 4, 2023
CompletedFirst Posted
Study publicly available on registry
September 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedSeptember 9, 2025
September 1, 2025
3.8 years
August 4, 2023
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome will be spontaneous preterm birth (sPTB) <34 weeks' gestation.
We will define sPTB as labour having occurred prior to 34+0 weeks of gestation in patients with either intact membranes or premature prelabour rupture of membranes (PPROM) (\<37 weeks). This excludes iatrogenic causes for preterm delivery including induction of labour (in the absence of PPROM) or elective C/S.
Women will be recruited at 16 weeks gestation, followed up at 28 weeks gestation and time of delivery. The primary outcome will be assessed once the participant has delivered, no later than 38 weeks gestation in a multiple pregnancy.
Eligibility Criteria
All monochorionic and dichorionic pregnancies at the Liverpool Women's Multiple Pregnancy Clinic will be approached for participation. This is a tertiary clinic caring for multiple pregnancies within Liverpool and the north west of England.
You may qualify if:
- Age ≥18 years
- Twin pregnancy
- Able to provide informed consent
You may not qualify if:
- Known or suspected severe structural/chromosomal fetal abnormality
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Liverpoollead
- Imperial College Londoncollaborator
- Liverpool Women's NHS Foundation Trustcollaborator
Study Sites (1)
Liverpool Women's NHS Foundation Trust
Liverpool, Merseyside, L8 7SS, United Kingdom
Biospecimen
Vaginal Swab Samples Plasma Serum Buffy Coat
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna L Gent, MBChB (Hons)
University of Liverpool
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2023
First Posted
September 26, 2023
Study Start
July 5, 2022
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
No plan to share IPD